This site uses cookies to improve your experience. To help us insure we adhere to various privacy regulations, please select your country/region of residence. If you do not select a country, we will assume you are from the United States. Select your Cookie Settings or view our Privacy Policy and Terms of Use.
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Used for the proper function of the website
Used for monitoring website traffic and interactions
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Strictly Necessary: Used for the proper function of the website
Performance/Analytics: Used for monitoring website traffic and interactions
Stämm Biotech , founded in 2014, is developing a desktop-sized bioreactor that looks pretty different from the tanks, tubes and knobs traditionally seen in industrial or even benchtop bioreactors. Instead, it’s developing a unit that 3D prints a dense network of microchannels that pass cells through the nutrients and oxygen they need.
Sifting through the trillions of molecules out there that might have powerful medicinal effects is a daunting task, but the solution biotech has found is to work smarter, not harder. Machine learning has, of course, accelerated work in many fields, biochemistry among them, but he felt that the potential of the technology had not been tapped.
Restor3d , a North Carolina-based maker of 3D printed personalized orthopedic implants, locked up a $70 million financing — even as investors continue to cool on 3D tech startups. “With this capital, we can accelerate our efforts to transform orthopedic care through 3D printed personalized implants.” .
New AI unicorns minted last year include: Elon Musk s foundation model company xAI, most recently valued at $50 billion; 3D immersive environment Infinite Reality, valued at $12 billion; AI search startup Perplexity, valued at $9 billion; Quantum computing services startup Quantinuum , valued at $5.3 leadership in AI.
tied) Prolific Machines , $55M, biotech: Unlike in previous weeks, there was no huge biotech round. tied) Restor3d , $55M, 3Dtechnology: Restor3d, a North Carolina-based maker of 3D printed personalized orthopedic implants, locked up a $70 million financing — even as investors continue to cool on 3D tech startups.
Biotech and AI had another strong week, as the sectors saw two big nine-figure rounds each — including one for $370 million in biotech. Candid Therapeutics , $370M, biotech: Every week there’s a big biotech raise — and this week there’s one that’s really big. Check out last week’s biggest funding rounds here.
Similarly, clothing brand Under Armour recently produced an ad that used AI-generated 3D models of the British boxer Anthony Joshua, based on videos they took of him in the past. As the technology exhausts its honeymoon period, and companies in all industries find new ways of using it to get ahead of the competition, a new race is on.
Mooji Meats: Speedy 3D printing whole cuts. The company has developed a 3D printer capable of producing whole cuts of meat using plant protein or cultured meat cells. They’re developing a 3D-printed cut of Wagyu beef, and expect a prototype to be viable for taste tests within six months, co-founder Insa Mohr told TechCrunch.
Yet, the R&D process for drug discovery relies on 2D monitors, keyboard, and mouse, which limits the understanding of complex 3D structures or interactions and contributes to massive R&D costs averaging $2.5B “Understanding structure empowers our users to understand how their designs function,” he wrote in an email. per drug.”.
Healthcare/biotech companies took the lead with three companies that joined the board from this sector. Google Ventures , US Innovative Technology Fund , General Catalyst , Founders Fund , Caffeinated Capital and angel investor Elad Gil each have two portfolio companies across this cohort. Who invested?
Two-year-old Fertilis’s technology to automate cell culture with micro medical devices has won support from some investors. ” Fertilis’s solution is to standardize and automate the IVF process by putting each embryo in its patented 3D-printed cradle. million ($1.98 million). .
Prellis Biologics , a company developing the tools to create 3D-printed organs, announced a $14.5 Up until this point, Prellis has focused on 3D printing vascular scaffolds that would allow companies to grow healthy and oxygenated human organs (or miniature versions, called organoids) for drug testing, and eventually transplant.
“These two are a powerhouse team who have the ability to completely shift our understanding of modern genetics while developing innovative technologies that not only help bring back lost species, but advance the entire industry,” Robbins tells TechCrunch. “I This is a 3D render illustration. Mammoth in the middle of mountains.
Medical technology, or “medtech” are intended to improve the quality of healthcare delivered through earlier diagnosis, less invasive treatment options and reduction in hospital stays and rehabilitation times. Medical technology or MedTech may include medical devices, information technology, biotech, and healthcare services.
New York counts a number of health tech companies that are leading the charge for this kind of technological usage, including WW, Cityblock Health, Crossix, Cedar, and more. . billion takeover of the market intelligence, data, and technology solutions firm Ipreo, as well as SS&C’s $1.5 3D modeling . and third-place London.
All these prompt the pharma industry to seek help from new technologies — and namely, artificial intelligence (AI) which holds a promise to speed up and otherwise improve drug discovery. HTS automates testing against targets, employing sensitive detectors, robotics, data processing software, and other technologies. Real-life example.
BPO partners manage technology upgrades and staff training, enabling businesses to save on tech stack, resource allocation, and training. Access to Expertise and Technology Business process outsourcing can help you engage professionals with extensive industry knowledge who unburden you from routine responsibilities.
One small company that stepped into the fray of swab production was the two-year-old OPT Industries, a Massachusetts-based company with 15 employees involved in additive manufacturing (think 3D printing) of dense microfiber structures. As COVID-19 surges, 3D printing is having a moment.
After 2 months in an underground shelter they have also used their technology to register evidence of war crimes and provide the ability to immerse oneself into Ukraine to experience it, it’s now developing applications for psychological trauma treatment, VR medical trainin, combat surveillance systems and making the de-mining process safer.
Today Femtech, female-focused technology startups designed to support women’s health is a major investment category. Femtech is an acronym for Female technology – are startups working on women’s health. Matisse” breast implants consist of 3D printed biomaterials and allow a natural reconstruction of the breast.
Usually the rounds with the most money or biggest-named investors get the headlines, but there were plenty of deals this year that were eye-catching just for the technology that was getting funded. The device has portable sensors containing rapid, on-site molecular detection technology that can find allergens, toxins and contaminants.
We organize all of the trending information in your field so you don't have to. Join 49,000+ users and stay up to date on the latest articles your peers are reading.
You know about us, now we want to get to know you!
Let's personalize your content
Let's get even more personalized
We recognize your account from another site in our network, please click 'Send Email' below to continue with verifying your account and setting a password.
Let's personalize your content